YCP-20666-60726
5 vaccinations
6 coded responses
42 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Dose 1 — Moderna
-
2021-03-12
Registered in v-safe
-
2021-03-12
Survey response — day 21, dose 1MedDRA: Injection site erythema — Feeling: GoodFree text: Redness around injection site, about 3 diameter, noticed 8 days after receiving first vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Dose 2 — Moderna
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-06-17
- 2021-09-16
-
2021-10-27
Dose 3 — Moderna
- 2021-10-28
- 2021-10-29
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Arthritis, Pain in extremity — Feeling: Good · Muscle or body achesFree text: Aches in opposite arm and arthritic hand on opposite sideMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
-
2022-01-26
Survey response — 3 months, dose 3MedDRA: Benign breast neoplasm, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Radial scar tissue found in breast. · Healthcare visit (other): Surgeon visitMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-28
-
2022-04-08
Dose 4 — Moderna
- 2022-04-18
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-07-09
-
2022-09-07
Dose 5 — Moderna
-
2022-10-07
Survey response — 6 months, dose 4MedDRA: Cough, Rhinorrhoea, Throat irritation — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Scratchy throat, drippy nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-09
Survey response — day 28, dose 5MedDRA: Cough, Headache, Increased upper airway secretion, Rhinorrhoea, Throat irritation — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Scratchy throat, cough, mucous from nose and throat, slight headache beginning October 18, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — day 35, dose 5MedDRA: Cough, Headache, Increased upper airway secretion, Rhinorrhoea, SARS-CoV-2 test negative, Secretion discharge, Throat irritation — Feeling: GoodFree text: Tested negative for COVID, but had a bit of a headache, then scratchy throat, followed by drainage from nose and mucous coughed up from throat.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
- 2022-12-07
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Moderna | |
| 2 | 2021-03-18 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
| 4 | 2022-04-08 | Moderna | No |
| 5 | 2022-09-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-26 | Unsuccessful |
Free text
Release 5 — day 21, dose 1
Symptoms: Redness around injection site, about 3 diameter, noticed 8 days after receiving first vaccination.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Aches in opposite arm and arthritic hand on opposite side
Release 11 — 3 months, dose 3
Release 12 — 6 months, dose 4
Symptoms: Scratchy throat, drippy nose, cough
Release 12 — day 28, dose 5
Symptoms: Scratchy throat, cough, mucous from nose and throat, slight headache beginning October 18, 2022
Release 12 — day 35, dose 5
Symptoms: Tested negative for COVID, but had a bit of a headache, then scratchy throat, followed by drainage from nose and mucous coughed up from throat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Benign breast neoplasm | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Increased upper airway secretion | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Arthritis | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release